PortalPublikationenOnco-Cardiology: Consensus Paper of the German Cardiac Socie...

Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology

Standard

Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology. / Rassaf, Tienush; Totzeck, Matthias; Backs, Johannes; Bokemeyer, Carsten; Hallek, Michael; Hilfiker-Kleiner, Denise; Hochhaus, Andreas; Lüftner, Diana; Müller, Oliver J; Neudorf, Ulrich; Pfister, Roman; von Haehling, Stephan; Lehmann, Lorenz H; Bauersachs, Johann; Committee for Clinical Cardiovascular Medicine of the German Cardiac Society.

in: CLIN RES CARDIOL, Jahrgang 109, Nr. 10, 10.2020, S. 1197-1222.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Rassaf, T, Totzeck, M, Backs, J, Bokemeyer, C, Hallek, M, Hilfiker-Kleiner, D, Hochhaus, A, Lüftner, D, Müller, OJ, Neudorf, U, Pfister, R, von Haehling, S, Lehmann, LH, Bauersachs, J & Committee for Clinical Cardiovascular Medicine of the German Cardiac Society 2020, 'Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology', CLIN RES CARDIOL, Jg. 109, Nr. 10, S. 1197-1222. https://doi.org/10.1007/s00392-020-01636-7

APA

Rassaf, T., Totzeck, M., Backs, J., Bokemeyer, C., Hallek, M., Hilfiker-Kleiner, D., Hochhaus, A., Lüftner, D., Müller, O. J., Neudorf, U., Pfister, R., von Haehling, S., Lehmann, L. H., Bauersachs, J., & Committee for Clinical Cardiovascular Medicine of the German Cardiac Society (2020). Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology. CLIN RES CARDIOL, 109(10), 1197-1222. https://doi.org/10.1007/s00392-020-01636-7

Vancouver

Rassaf T, Totzeck M, Backs J, Bokemeyer C, Hallek M, Hilfiker-Kleiner D et al. Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology. CLIN RES CARDIOL. 2020 Okt;109(10):1197-1222. https://doi.org/10.1007/s00392-020-01636-7

Bibtex

@article{d926bf5be4bc41dabbfc8fd4f3c8304a,
title = "Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology",
abstract = "The acute and long-lasting side effects of modern multimodal tumour therapy significantly impair quality of life and survival of patients afflicted with malignancies. The key components of this therapy include radiotherapy, conventional chemotherapy, immunotherapy and targeted therapies. In addition to established tumour therapy strategies, up to 30 new therapies are approved each year with only incompletely characterised side effects. This consensus paper discusses the risk factors that contribute to the development of a potentially adverse reaction to tumour therapy and, in addition, defines specific side effect profiles for different treatment groups. The focus is on novel therapeutics and recommendations for the surveillance and treatment of specific patient groups.",
author = "Tienush Rassaf and Matthias Totzeck and Johannes Backs and Carsten Bokemeyer and Michael Hallek and Denise Hilfiker-Kleiner and Andreas Hochhaus and Diana L{\"u}ftner and M{\"u}ller, {Oliver J} and Ulrich Neudorf and Roman Pfister and {von Haehling}, Stephan and Lehmann, {Lorenz H} and Johann Bauersachs and {Committee for Clinical Cardiovascular Medicine of the German Cardiac Society}",
year = "2020",
month = oct,
doi = "10.1007/s00392-020-01636-7",
language = "English",
volume = "109",
pages = "1197--1222",
journal = "CLIN RES CARDIOL",
issn = "1861-0684",
publisher = "D. Steinkopff-Verlag",
number = "10",

}

RIS

TY - JOUR

T1 - Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology

AU - Rassaf, Tienush

AU - Totzeck, Matthias

AU - Backs, Johannes

AU - Bokemeyer, Carsten

AU - Hallek, Michael

AU - Hilfiker-Kleiner, Denise

AU - Hochhaus, Andreas

AU - Lüftner, Diana

AU - Müller, Oliver J

AU - Neudorf, Ulrich

AU - Pfister, Roman

AU - von Haehling, Stephan

AU - Lehmann, Lorenz H

AU - Bauersachs, Johann

AU - Committee for Clinical Cardiovascular Medicine of the German Cardiac Society

PY - 2020/10

Y1 - 2020/10

N2 - The acute and long-lasting side effects of modern multimodal tumour therapy significantly impair quality of life and survival of patients afflicted with malignancies. The key components of this therapy include radiotherapy, conventional chemotherapy, immunotherapy and targeted therapies. In addition to established tumour therapy strategies, up to 30 new therapies are approved each year with only incompletely characterised side effects. This consensus paper discusses the risk factors that contribute to the development of a potentially adverse reaction to tumour therapy and, in addition, defines specific side effect profiles for different treatment groups. The focus is on novel therapeutics and recommendations for the surveillance and treatment of specific patient groups.

AB - The acute and long-lasting side effects of modern multimodal tumour therapy significantly impair quality of life and survival of patients afflicted with malignancies. The key components of this therapy include radiotherapy, conventional chemotherapy, immunotherapy and targeted therapies. In addition to established tumour therapy strategies, up to 30 new therapies are approved each year with only incompletely characterised side effects. This consensus paper discusses the risk factors that contribute to the development of a potentially adverse reaction to tumour therapy and, in addition, defines specific side effect profiles for different treatment groups. The focus is on novel therapeutics and recommendations for the surveillance and treatment of specific patient groups.

U2 - 10.1007/s00392-020-01636-7

DO - 10.1007/s00392-020-01636-7

M3 - SCORING: Review article

C2 - 32405737

VL - 109

SP - 1197

EP - 1222

JO - CLIN RES CARDIOL

JF - CLIN RES CARDIOL

SN - 1861-0684

IS - 10

ER -